JPWO2021203104A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021203104A5 JPWO2021203104A5 JP2022560207A JP2022560207A JPWO2021203104A5 JP WO2021203104 A5 JPWO2021203104 A5 JP WO2021203104A5 JP 2022560207 A JP2022560207 A JP 2022560207A JP 2022560207 A JP2022560207 A JP 2022560207A JP WO2021203104 A5 JPWO2021203104 A5 JP WO2021203104A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- nucleic acid
- epitope
- encoding nucleic
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063005160P | 2020-04-03 | 2020-04-03 | |
| US63/005,160 | 2020-04-03 | ||
| PCT/US2021/025828 WO2021203104A1 (en) | 2020-04-03 | 2021-04-05 | Infectious disease antigens and vaccines |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023521662A JP2023521662A (ja) | 2023-05-25 |
| JP2023521662A5 JP2023521662A5 (https=) | 2024-04-17 |
| JPWO2021203104A5 true JPWO2021203104A5 (https=) | 2024-04-17 |
Family
ID=77929685
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022560207A Pending JP2023521662A (ja) | 2020-04-03 | 2021-04-05 | 感染症抗原及びワクチン |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240050550A1 (https=) |
| EP (1) | EP4125944A4 (https=) |
| JP (1) | JP2023521662A (https=) |
| KR (1) | KR20230006825A (https=) |
| CN (1) | CN115942942A (https=) |
| AU (1) | AU2021247302A1 (https=) |
| CA (1) | CA3173793A1 (https=) |
| IL (1) | IL296752A (https=) |
| WO (1) | WO2021203104A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023066874A1 (en) * | 2021-10-18 | 2023-04-27 | BioNTech SE | Methods for determining mutations for increasing modified replicable rna function and related compositions and their use |
| AU2023356120A1 (en) * | 2022-10-07 | 2025-04-17 | The Trustees Of Indiana University | Recombinant rotaviruses and methods and systems for producing the same |
| EP4604997A2 (en) * | 2022-10-21 | 2025-08-27 | PDS Biotechnology Corporation | Recombinant protein vaccines formulated with enantio-specific cationic lipid r-dotap and methods of use thereof |
| CN116218889A (zh) * | 2022-12-13 | 2023-06-06 | 浙江大学 | 一种表达猫细小病毒VP2蛋白的mRNA疫苗及其制备方法 |
| CN120168624B (zh) * | 2024-12-31 | 2025-11-04 | 今发制药(南京)有限公司 | 一种伪狂犬免疫原组合物及其用途 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6770283B1 (en) * | 1990-12-13 | 2004-08-03 | Bioption Ab | DNA expression systems based on alphaviruses |
| US6015686A (en) * | 1993-09-15 | 2000-01-18 | Chiron Viagene, Inc. | Eukaryotic layered vector initiation systems |
| ATE449105T1 (de) * | 2004-01-23 | 2009-12-15 | Angeletti P Ist Richerche Bio | Impfstoffträger für schimpansen-adenovirus |
| US20110300205A1 (en) * | 2009-07-06 | 2011-12-08 | Novartis Ag | Self replicating rna molecules and uses thereof |
| SG11201706118XA (en) * | 2015-01-29 | 2017-08-30 | Agency Science Tech & Res | Nanocapsules carrying chikungunya-associated peptides |
| TW201729835A (zh) * | 2015-10-22 | 2017-09-01 | 現代公司 | 呼吸道病毒疫苗 |
| JP2019511255A (ja) * | 2016-01-11 | 2019-04-25 | バーンダリ，インク． | マイクロニードル組成物およびそれを使用する方法 |
| MX2019013259A (es) * | 2017-05-08 | 2020-01-13 | Gritstone Oncology Inc | Vectores de neoantigeno de alfavirus. |
| EP3836963A2 (en) * | 2018-08-17 | 2021-06-23 | GlaxoSmithKline Biologicals S.A. | Immunogenic compositions and uses thereof |
| IL303315A (en) * | 2020-12-02 | 2023-07-01 | Seqirus Inc | Multicistronic RNA components and their uses |
-
2021
- 2021-04-05 EP EP21780767.6A patent/EP4125944A4/en active Pending
- 2021-04-05 AU AU2021247302A patent/AU2021247302A1/en active Pending
- 2021-04-05 IL IL296752A patent/IL296752A/en unknown
- 2021-04-05 JP JP2022560207A patent/JP2023521662A/ja active Pending
- 2021-04-05 WO PCT/US2021/025828 patent/WO2021203104A1/en not_active Ceased
- 2021-04-05 KR KR1020227038618A patent/KR20230006825A/ko active Pending
- 2021-04-05 CN CN202180040267.1A patent/CN115942942A/zh active Pending
- 2021-04-05 CA CA3173793A patent/CA3173793A1/en active Pending
-
2022
- 2022-10-03 US US17/937,751 patent/US20240050550A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021525076A5 (https=) | ||
| JPWO2019226941A5 (https=) | ||
| JP2021524247A5 (https=) | ||
| JP5016305B2 (ja) | 改良されたアルファウイルスレプリコンおよびヘルパー構築物 | |
| RU2019119272A (ru) | Вирусная доставка неоантигенов | |
| Lundstrom | Alphavirus vectors for vaccine production and gene therapy | |
| JP2018536433A5 (https=) | ||
| JPWO2021236854A5 (https=) | ||
| JP2017503482A5 (https=) | ||
| TWI769467B (zh) | 用作b型肝炎病毒(hbv)疫苗之自我複製rna分子及其用途 | |
| CN114854773A (zh) | 顺式复制子构建体 | |
| JP2004501646A5 (https=) | ||
| JPWO2012053646A1 (ja) | ワクシニアウイルスベクターおよびセンダイウイルスベクターからなるプライム／ブーストワクチン用ウイルスベクター | |
| BR112015023524B1 (pt) | Vírus vaccinia ankara modificado, composição compreendendo o dito vírus e uso do mesmo para primagem ou reforço de uma resposta imune | |
| CA3188801A1 (en) | Rna replicon vaccines against hbv | |
| CN106459997A (zh) | 用于疫苗应用的高效价病毒样囊泡的进化 | |
| JPWO2019226939A5 (https=) | ||
| WO2022133230A1 (en) | Combination therapy for treating hepatitis b virus infection | |
| JPWO2022032196A5 (https=) | ||
| JPWO2020097393A5 (https=) | ||
| JPWO2020243719A5 (https=) | ||
| EP0800579B1 (en) | Combination gene delivery vehicles | |
| JPWO2021203104A5 (https=) | ||
| JPWO2021003348A5 (https=) | ||
| CN113430178B (zh) | 一种表达ii型单纯疱疹病毒蛋白的重组流感病毒株及其制备方法与应用 |